Actinogen Medical
- Biotech or pharma, therapeutic R&D
Actinogen (ASX:ACW) is conducting Ph 2 trials of an oral, small molecule for Alzheimer’s Disease (AD) and Depression. Xanamem® works by a novel, non-amyloid mechanism to reduce tissue cortisol which is highly associated with cognitive impairment.
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}